中信证券股份有限公司 关于佳缘科技股份有限公司 2024 年度内部控制自我评价报告的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为佳缘科 技股份有限公司（以下简称"佳缘科技"、"公司"）首次公开发行股票并在创业 板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所 创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业 板上市公司规范运作》及《深圳证券交易所上市公司自律监管指引第 13 号—— 保荐业务》等相关法律法规和规范性文件的规定，在持续督导期内，对《佳缘科 技股份有限公司 2024 年度内部控制自我评价报告》进行了核查，情况如下： 一、重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其 有效性，并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建 立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运行。公 司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假 记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个 别及连带法律责任。 公司内部控制的目标是合理 ...

中信证券股份有限公司 关于佳缘科技股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为佳缘科 技股份有限公司（以下简称"佳缘科技"、"公司"）首次公开发行股票并在创业 板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》及《上市公司监管指引第 2 号——上市公司募集资金管理和使用 的监管要求》等相关法律法规和规范性文件的规定，在持续督导期内，对佳缘科 技使用部分闲置募集资金进行现金管理的事项进行了审慎核查，并发表如下意见： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意佳缘科技股份有限公司首次公开发行 股票注册的批复》（证监许可[2021]3309 号）同意注册，公司首次公开发行人民 币普通股（A 股）股票 2,307.33 万股，每股面值 1 元，每股发行价格为人民币 46.80 元，募集资金总额为人民币 107,983.04 万元，扣除本次发行费用（不含税） 后，实际募集资金净额为人民币 99,499.28 万元。 上述 ...

为满足公司各项业务顺利进行及日常经营资金需求，提高决策效率，公司拟 向金融机构申请总额不超过人民币 2.5 亿元的综合授信额度，授信期限为 1 年， 综合授信用途包括但不限于流动资金贷款、银行承兑汇票、保函开立等。 公司董事会授权公司法定代表人或其指定的授权代理人办理上述授信额度 申请事宜并签署相关合同等文件，授权期限为自董事会审议通过之日起一年内。 上述授权额度不等于公司实际融资金额，具体融资金额将视公司运营资金的 实际需求来确定，实际授信额度、利率、期限、用途等以银行实际批准为准。 二、关联交易概述 中信证券股份有限公司 关于佳缘科技股份有限公司 向金融机构申请综合授信额度并接受关联方提供担保的 核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为佳缘科 技股份有限公司（以下简称"佳缘科技"、"公司"）首次公开发行股票并在创业 板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》等相关法律法规和规范性文件的规定，在持续督导期内，对佳缘 科技向金融机构申请综合授信额度并接受关联方 ...

佳缘科技股份有限公司 内部控制审计报告 二、 注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的 有效性发表审计意见，并对注意到的非财务报告内部控制的重大缺陷 进行披露。 三、 内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策 和程序遵循的程度降低，根据内部控制审计结果推测未来内部控制的 有效性具有一定风险。 2024 年度 内部控制审计报告 信会师报字[2025]第 ZA90437 号 佳缘科技股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求，我们审计了上海佳缘科技股份有限公司（以下简称佳缘科技） 2024 年 12 月 31 日的财务报告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定，建立健全和有效实施内部控制，并评 价其有效性是佳缘科技董事会的责任。 中国注册会计师： 中国•上海 二○二五年四月二十二日 内部控制审计报告 第2页 内部控制审计报告 第1页 四、 ...

佳缘科技股份有限公司 独立董事 2024 年度述职报告 （杨倩娥） 各位股东及股东代表： 本人杨倩娥作为佳缘科技股份有限公司（以下简称"公司"）第三届董事 会独立董事、战略与投资委员会委员、审计委员会委员、提名委员会委员、薪 酬与考核委员会委员，在 2024 年度任职期间严格按照《中华人民共和国公司 法》《中华人民共和国证券法》《上市公司独立董事规则》《深圳证券交易所 创业板股票上市规则》等法律、法规和规范性文件以及《公司章程》《独立董 事工作制度》等规定和要求，本着维护公司利益和股东尤其是中小股东的权益 的原则，诚信、勤勉、尽责、独立履行职务，积极参与公司的各项事务，认真 审议董事会各项议案，客观、公正、独立地履行职责。现将 2024 年度工作情况 报告如下： 一、报告期内出席董事会和股东大会情况 2024 年度，公司共召开了 7 次董事会会议和 4 次股东大会会议，本人按时 出席了 7 次董事会、4 次股东大会，没有缺席或连续两次未亲自出席会议的情 况。 本人出席会议情况如下： | | 本报告 | 现场出 | 以通讯 | 委托出 | 缺席 | 是否连续 | 出席股 | | --- | --- | --- ...

佳缘科技股份有限公司 独立董事 2024 年度述职报告 （赵宇虹） 各位股东及股东代表： 本人赵宇虹作为佳缘科技股份有限公司（以下简称"公司"）第三届董事会 独立董事、审计委员会委员（主任委员）、提名委员会委员（主任委员）、薪酬 与考核委员会委员（主任委员），在 2024 年度任职期间严格按照《中华人民共 和国公司法》《中华人民共和国证券法》《上市公司独立董事规则》《深圳证券 交易所创业板股票上市规则》等法律、法规和规范性文件以及《公司章程》《独 立董事工作制度》等规定和要求，本着维护公司利益和股东尤其是中小股东的权 益的原则，诚信、勤勉、尽责、独立履行职务，积极参与公司的各项事务，认真 审议董事会各项议案，客观、公正、独立地履行职责。现将 2024 年度工作情况 报告如下： 一、报告期内出席董事会和股东大会情况 2024 年度，公司共召开了 4 次董事会会议和 3 次股东大会会议，本人按时 出席了 4 次董事会、3 次股东大会，没有缺席或连续两次未亲自出席会议的情况。 本人出席会议情况如下： | | 本报告 | 现场出 | 以通讯 | 委托出 | 缺席 | 是否连续 | 出席股 | | --- | --- ...

佳缘科技股份有限公司 董事会关于独立董事独立性评估的专项意见 根据《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等要求，佳缘科技股份有限公司（以下简称"公司"）董事会就公司在任独立董 事肖军、赵宇虹的独立性情况进行评估并出具如下专项意见： 经核查独立董事肖军、赵宇虹的任职经历以及签署的相关自查文件，上述人 员未在公司担任除独立董事以外的任何职务，也未在公司主要股东公司担任任何 职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系。综上，公司独立董事符合《上市公司独立董事管理办法》《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中对独立 董事独立性的相关要求。 佳缘科技股份有限公司 董事会 2025 年 4 月 24 日 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥22,117,341.59, representing a 35.66% increase compared to ¥16,303,006.10 in the same period last year[5] - The net loss attributable to shareholders was ¥14,409,054.51, an improvement of 8.83% from a loss of ¥15,805,349.87 in the previous year[5] - The company’s basic and diluted earnings per share were both -¥0.16, showing a 5.88% improvement from -¥0.17 in the previous year[5] - Net profit for the current period was ¥-15,019,204.03, compared to ¥-16,208,018.34 in the previous period, showing an improvement of approximately 7.3%[26] - Total operating costs amounted to ¥41,893,222.77, up from ¥37,646,335.81, indicating an increase of about 6.3%[25] Cash Flow and Liquidity - The net cash flow from operating activities was -¥81,523,823.15, a decline of 151.95% compared to -¥32,357,041.59 in the same period last year[5] - Operating cash inflow totaled $39,170,610.94, down 26.1% from $52,976,305.82 in the previous period[29] - Cash outflow from operating activities increased to $120,694,434.09, up 41.4% from $85,333,347.41 in the previous period[30] - Cash inflow from investment activities was $130,689,361.10, down 64.0% from $362,349,016.74 in the previous period[30] - The ending cash and cash equivalents balance was $336,132,675.98, down from $491,382,239.48 in the previous period[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,488,443,408.80, down 2.75% from ¥1,530,596,654.60 at the end of the previous year[5] - The company’s total liabilities decreased significantly, with other current liabilities dropping by 89.54% to ¥285,000.00 from ¥2,723,920.51[10] - Total liabilities decreased to ¥181,302,307.64 from ¥209,991,434.57, a reduction of approximately 13.8%[24] - The total equity attributable to shareholders was ¥1,301,641,476.92, down from ¥1,314,706,171.80, indicating a decrease of about 1.0%[24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,613[15] - The total number of restricted shares held by major shareholders decreased to 35,513,381.0 shares, down from 46,444,756.0 shares, reflecting a reduction of approximately 23.5%[19] - The company’s major shareholder, Wang Jin, directly holds 37.68% of the company's shares, with an additional indirect holding of 0.12% through a partnership, totaling 37.80%[18] - The company has a significant shareholder relationship, with Wang Jin and Yin Mingjun collectively holding 37.97% of the shares[18] Operational Changes - The company completed the registration of changes in its business license, with the legal representative changed from Wang Jin to Zhu Weimin as of March 3, 2025[20] - The company reported a significant increase in accounts receivable financing, which rose by 968.27% to ¥13,374,074.58 from ¥1,251,932.91[10] - The company’s prepayments rose to CNY 13,664,074.86 from CNY 3,916,160.44, indicating an increase of approximately 249.5%[22] Government Support - The company received government subsidies amounting to ¥61,151.93, which are closely related to its regular business operations[6] Research and Development - Research and development expenses for the current period were ¥14,951,680.48, slightly up from ¥14,000,612.82, reflecting an increase of about 6.8%[26] Audit and Governance - The company did not undergo an audit for the first quarter report[31] - The board of directors meeting was held on April 24, 2025[32]

Financial Performance - The company's revenue for 2024 reached ¥336,799,849.27, representing a 48.11% increase compared to ¥227,392,776.98 in 2023[19]. - The net profit attributable to shareholders for 2024 was ¥11,445,371.40, a significant turnaround from a loss of ¥5,352,891.52 in 2023, marking a 313.82% improvement[19]. - The basic earnings per share for 2024 increased to ¥0.12, compared to a loss of ¥0.06 per share in 2023, reflecting a 300.00% growth[19]. - The total assets of the company as of the end of 2024 amounted to ¥1,530,596,654.60, which is a 7.52% increase from ¥1,423,596,090.48 at the end of 2023[19]. - The company reported a cash flow from operating activities net amount of -¥50,830,933.56 for 2024, showing a slight improvement of 3.10% from -¥52,457,560.47 in 2023[19]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥3,303,725.63, a 120.29% increase from a loss of ¥16,280,503.83 in 2023[19]. - The weighted average return on equity for 2024 was 0.87%, recovering from -0.41% in 2023[19]. - The company received government subsidies amounting to ¥3,349,365.57 in 2024, which positively impacted its financial performance[25]. - The company achieved a revenue of CNY 336.80 million in 2024, representing a year-on-year growth of 48.11%[57]. - Net profit attributable to shareholders reached CNY 11.45 million, up 313.82% year-on-year, while the net profit after deducting non-recurring gains and losses increased by 120.29% to CNY 3.30 million[57]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 0.2 RMB per 10 shares to all shareholders, totaling approximately 18.45 million RMB based on 92,263,300 shares[5]. - The profit distribution proposal includes a capital reserve conversion of 4 additional shares for every 10 shares held by shareholders[5]. - The company will not distribute cash dividends for the fiscal year 2023, nor will it issue bonus shares or convert capital reserves into share capital[164]. - The proposed cash dividend for the fiscal year 2024 is set at 0.2 yuan per 10 shares, with a total expected cash dividend of 1,845,266 yuan[166]. - The company plans to increase its total share capital to 129,168,620 shares after a proposed capital reserve conversion of 4 shares for every 10 shares held[166]. Governance and Compliance - The report confirms that all board members attended the meeting to review the annual report, ensuring accountability for the report's accuracy[5]. - The financial report is guaranteed to be true, accurate, and complete by the company's responsible personnel, including the CEO and accounting head[5]. - The company has established a governance structure that ensures equal rights for all shareholders, particularly minority shareholders, and guarantees their participation in major decisions[125]. - The board of directors consists of 5 members, including 2 independent directors, meeting the legal requirements for board composition[126]. - The company has implemented a strategic committee, a compensation and assessment committee, an audit committee, and a nomination committee, with independent directors leading most of these committees[126]. - The company has not reported any instances of the controlling shareholder interfering with its decision-making or operations, maintaining an independent business structure[125]. - The company has a dedicated supervisory board with 3 members, ensuring compliance and oversight of major transactions and financial conditions[126]. - The company has disclosed its market expansion strategies and future product development plans during investor communications[121][122]. - The company has adhered to disclosure requirements related to cybersecurity business as per the Shenzhen Stock Exchange guidelines[62]. - The company has not provided any guarantees or loans to its controlling shareholders or their enterprises[130]. Market and Strategic Initiatives - The company is focused on expanding its market presence and enhancing its product offerings through new technologies and strategic initiatives[11]. - The company has engaged in strategic partnerships to enhance its technological capabilities and market reach[27]. - The company is actively expanding its market presence, particularly in the military and healthcare sectors, to enhance its competitive edge[58]. - The company is exploring acquisition opportunities to enhance its product offerings and market presence[7]. - The company aims to increase its market share in the healthcare informatization sector by leveraging growth opportunities in regional healthcare and emerging technology applications[33]. - The company plans to enhance market competitiveness through deeper business expansion, contributing to increased sales volume[67]. Research and Development - The company has established a robust technology R&D system, focusing on new product development in data security and information technology solutions[54]. - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience[5]. - R&D investment amounted to ¥63,109,499.31 in 2024, representing 18.74% of operating revenue, a decrease from 27.88% in 2023[87]. - The company has completed several medical data management systems and plans to advance its medical + big data projects, including the development of version 3.0 of the electronic medical record system[113]. - The company is focusing on developing specialized chips based on network security coding applications, with two projects (SIP100 and SIP400) in the pipeline for research and production[113]. Employee and Talent Management - The company has established a comprehensive training system and annual training plans to enhance employee skills and career development[162]. - The company has implemented a mentorship program to enhance new employee integration and skill development, fostering a collaborative work environment[163]. - The company is implementing measures to reduce talent turnover and enhance talent management through improved incentive systems and performance evaluations[119]. - The company has committed to not laying off employees or reducing salaries, while actively recruiting talent to support business development[181]. - The company provides comprehensive welfare benefits to employees, including various types of insurance and paid leave[181]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts, indicating that these do not constitute binding commitments to investors[5]. - The management discussion section outlines potential risks in the company's future development, which investors are advised to pay attention to[5]. - The company is exposed to accounts receivable collection risks, particularly due to the complex payment approval processes of its main clients, which include government and military entities[118]. - The company anticipates order fluctuations due to changes in procurement policies or approval processes within the network information security industry[119]. Social Responsibility and Environmental Compliance - The company has actively engaged in social responsibility, adhering to laws and regulations while promoting green and low-carbon development[179]. - The company has no reported environmental penalties during the reporting period, indicating compliance with environmental regulations[179]. - The company actively participates in social responsibility and public welfare initiatives, promoting local economic development[181]. Shareholder Relations - The company conducted multiple investor relations activities throughout 2024, including on-site research and online communication, focusing on performance, product technology, and market conditions[121][122][123][124][125][126]. - The company has committed to maintaining stock price stability, with a plan to repurchase shares if the stock price falls below the audited net asset value per share for 20 consecutive trading days within three years post-IPO[190]. - The company will ensure that all related party transactions are disclosed and conducted at fair market prices, adhering to relevant laws and regulations[189]. - The company has pledged to avoid transferring profits through related party transactions and will seek to maintain transparency and fairness in all dealings[190].

人民财讯3月14日电，佳缘科技(301117)3月14日晚间公告，公司持股1.95%的特定股东厦门鑫瑞集英创 业投资合伙企业（有限合伙）（简称"鑫瑞集英"）计划以大宗交易方式和/或集中竞价交易方式合计减 持公司股份不超过180万股（占公司总股本的1.95%）。 ...